Sol-Gel Technologies (SLGL) Assets Growth (3y) (2019 - 2026)

Sol-Gel Technologies (SLGL) Assets Growth (3y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.08%
Dec 31, 2025 -13.75%
Sep 30, 2025 -12.30%
Jun 30, 2025 -10.58%
Mar 31, 2025 -21.55%
Dec 31, 2024 -19.68%
Sep 30, 2024 -6.64%
Jun 30, 2024 -3.27%
Mar 31, 2024 -9.37%
Dec 31, 2023 -8.52%
Sep 30, 2023 -9.08%
Jun 30, 2023 -9.62%
Mar 31, 2023 -13.89%
Dec 31, 2022 -8.72%
Sep 30, 2022 -8.92%
Jun 30, 2022 -4.63%
Mar 31, 2022 -6.23%
Dec 31, 2021 -0.24%
Sep 30, 2021 -13.15%
Jun 30, 2021 -18.70%